Education
Minning graduated from Melbourne High School in 1988 and was a member of the team that captured the Girl"s Soccer State Championship in 1987.
Minning graduated from Melbourne High School in 1988 and was a member of the team that captured the Girl"s Soccer State Championship in 1987.
In 1999, The New York Times, Science Daily and the Duke Chronicle covered her work on the Ascaris haemoglobin stating "The discovery may yield new therapies for diseases such as cancer, in which starving tumors of oxygen is a major therapeutic focus". In 2014, she published in Nature on the efficacy of BCX4430 against Marburg virus and published an additional paper on the activity of BCX4430 against Yellow Fever. On July 24, 2015, Minning announced her candidacy for the United States House of Representatives for Florida"s 9th congressional district.
She earned her Bachelor of Science degree (Phi Beta Kappa, High Honors) from the University of Florida.
Minning was a student in the Medical Scientist Training Program, earned her Doctor of Medicine (Alpha Omega Alpha) and Doctor of Philosophy in biochemistry and molecule cell biology (Spencer T Olin Fellow) from Washington University, School of Medicine. Minning"s medical research has been published Nature and in The New York Times, among other publications.
Minning completed her internship in internal medicine at the University of California, San Francisco. Minning worked as biotechnology consultant at MEDACorp from 2002-2003.
From 2003 to 2008, Minning served as an Associate Director of Licensing and Director of Medical Sciences at Amgen, where she developed new treatments for grave diseases, such as asthma, anemia, hyperlipidemia, myelodysplastic syndromes, heart failure, and pain.
While at Amgen, Minning was selected as a Henry Crown Fellow at the Aspen Institute in 2006. Minning then served as Vice President of Translational Sciences at 3-V Biosciences from 2008 to 2010, where she oversaw the development of broad-spectrum antiviral drugs. Minning served as the Vice President of Translational Sciences for AlloCure from 2011 to 2014, where she led research activities for a mesenchymal stem cell therapy for acute kidney injury.
In 2010, Minning founded MedExpert Consulting, a biotechnology consulting company, where she helped research and develop a broad-spectrum antiviral drug active against Ebola, Yellow Fever and other deadly viral diseases.
Phi Beta Kappa Society]
Minning is a member of the Democratic party.